These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5081391)

  • 1. [Action of dextran on the lysis of erythrocytes in nocturnal paroxysmal hemoglobinuria. Studies in vivo and in vitro].
    Tejero Lamarca J; Yangüela Terroba J; Martínez Santos P; Llorente Pérez L
    Sangre (Barc); 1972; 17(3):378-85. PubMed ID: 5081391
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro studies on the effects of dextrans of various molecular weights on the hemolysis of erythrocytes in nocturnal paroxysmal hemoglobinuria].
    Struzik T; Kowalczyk M; Frendo J
    Pol Tyg Lek; 1969 Jul; 24(27):1061-4. PubMed ID: 5805886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of preparation Fluidex (Dextran 40,000) on hemolysis and post-transfusion reactions in nocturnal paroxysmal hemoglobinuria].
    Struzik T; Kowalczyk M; Frendo J
    Pol Tyg Lek; 1969 Jul; 24(27):1064-7. PubMed ID: 5805887
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo effects of various therapies on complement-sensitive erythrocytes in paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Saitoh Y; Noji H; Terasawa T; Maruyama Y
    Int J Hematol; 1996 Jun; 63(4):291-302. PubMed ID: 8762812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxysmal nocturnal hemoglobinuria: the effect of dextran on hemolysis in vitro.
    CROSBY WH; BENJAMIN NR
    Acta Haematol; 1958; 19(4-5):193-8. PubMed ID: 13558967
    [No Abstract]   [Full Text] [Related]  

  • 6. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    SIRCHIA G; FERRONE S; MERCURIALI F
    Blood; 1965 Apr; 25():502-10. PubMed ID: 14284339
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab.
    Risitano AM; Notaro R; Luzzatto L; Hill A; Kelly R; Hillmen P
    N Engl J Med; 2010 Dec; 363(23):2270-2. PubMed ID: 21121856
    [No Abstract]   [Full Text] [Related]  

  • 8. THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    YACHNIN S; RUTHENBERG JM
    J Clin Invest; 1965 Apr; 44(4):518-34. PubMed ID: 14278168
    [No Abstract]   [Full Text] [Related]  

  • 9. COEXISTENT PAROXYSMAL NOCTURNAL AND COLD HEMOGLOBINURIA PRECEDED BY APLASTIC ANEMIA: A CASE REPORT AND FAMILY STUDY.
    MENGEL CE; HYMAN BN; O'MALLEY BW; HOWELL DA
    Blood; 1964 Oct; 24():451-7. PubMed ID: 14220787
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical dextran for acute episodes in paroxysmal nocturnal haemoglobinuria.
    STRATTON F; WILKINSON JF; ISRAELS MC
    Lancet; 1958 Apr; 1(7025):831. PubMed ID: 13526288
    [No Abstract]   [Full Text] [Related]  

  • 11. PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CURRENT CONCEPTS OF CERTAIN PATHOPHYSIOLOGIC FEATURES.
    HARTMANN RC; JENKINS DE
    Blood; 1965 May; 25():850-65. PubMed ID: 14282055
    [No Abstract]   [Full Text] [Related]  

  • 12. INCREASED HEMOLYSIS AFTER INTRAMUSCULAR IRON ADMINISTRATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. REPORT OF SIX OCCURRENCES IN FOUR PATIENTS, AND SPECULATIONS ON A POSSIBLE MECHANISM.
    MENGEL CE; KANN HE; O'MALLEY BW
    Blood; 1965 Jul; 26():74-81. PubMed ID: 14314402
    [No Abstract]   [Full Text] [Related]  

  • 13. Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria.
    Tomita A; Shirasugi Y; Ito T; Tsurumi H; Naoe T
    Ann Hematol; 2012 Jul; 91(7):1139-41. PubMed ID: 22080148
    [No Abstract]   [Full Text] [Related]  

  • 14. [NOCTURNAL PAROXYSMAL HEMOGLOBINURIA: STUDIES IN VITRO AND IN VIVO ON THE SUSCEPTIBILITY OF HEMOLYSIS TO A MERCAPTANE COMPOUND (PENICILLAMINE)].
    VON FELTEN
    Acta Haematol; 1964 Sep; 32():168-82. PubMed ID: 14227136
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria.
    Keating GM; Lyseng-Williamson KA; McKeage K
    BioDrugs; 2012 Apr; 26(2):125-30. PubMed ID: 22350448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vitamin E on haemolysis in paroxysmal nocturnal haemoglobinuria: in vitro and in vivo studies.
    Gomperts ED; Zail SS; Christensen D; Metz J
    Scand J Haematol; 1975 Apr; 14(2):81-5. PubMed ID: 1145115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into paroxysmal nocturnal hemoglobinuria.
    Savage WJ; Brodsky RA
    Hematology; 2007 Oct; 12(5):371-6. PubMed ID: 17852463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.
    Berzuini A; Montanelli F; Prati D
    N Engl J Med; 2010 Sep; 363(10):993-4. PubMed ID: 20818912
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenothiazine on the red cells of paroxysmal nocturnal haemoglobinuria.
    Laforet MT; Gardner FH
    Br J Haematol; 1968 Apr; 14(4):345-50. PubMed ID: 5643287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.